How much profit has Wize Pharma made this year?
Wize Pharma has made -486.32 M USD this year.
Wize Pharma Net Income 2024
Wize Pharma Net Income
-486.32 M USD
Ticker
WIZP
ISIN
US97751M2070
In 2024, Wize Pharma's profit amounted to -486.32 M USD, a 0% increase from the -486.32 M USD profit recorded in the previous year.
The Wize Pharma Net Income history
| YEAR | NET INCOME (undefined USD) |
|---|---|
| 2024e | -486,323.58 |
| 2023e | -486,323.58 |
| 2022e | - |
| 2021e | - |
| 2020 | -4,929 |
| 2019 | -3,450 |
| 2018 | -3,279 |
| 2017 | -2,966 |
| 2016 | -916 |
| 2015 | -1,477 |
| 2014 | -1,195 |
| 2013 | -2,840 |
| 2012 | -1,860 |
| 2011 | -1,400 |
| 2010 | -20 |
| 2009 | - |
| 2008 | -30 |
| 2007 | -20 |
| 2006 | 10 |
Wize Pharma Revenue, EBIT, Net Income US97751M2070 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Wize Pharma, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Wize Pharma from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Wize Pharma’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Wize Pharma. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Wize Pharma’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Wize Pharma’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Wize Pharma’s growth potential.
Wize Pharma Revenue, EBIT and net profit per share
| Date | Wize Pharma Revenue | Wize Pharma EBIT | Wize Pharma Net Income |
|---|---|---|---|
| 2024e | -9,236.1 TT undefined | 0 undefined | -486.32 M undefined |
| 2023e | -9,179.24 TT undefined | 0 undefined | -486.32 M undefined |
| 2022e | 0 undefined | 0 undefined | 0 undefined |
| 2021e | 0 undefined | 0 undefined | 0 undefined |
| 2020 | 0 undefined | -2.44 M undefined | -4.93 M undefined |
| 2019 | 0 undefined | -3.17 M undefined | -3.45 M undefined |
| 2018 | 0 undefined | -3.63 M undefined | -3.28 M undefined |
| 2017 | 0 undefined | -1.48 M undefined | -2.97 M undefined |
| 2016 | 0 undefined | -631,000 undefined | -916,000 undefined |
| 2015 | 0 undefined | -1.39 M undefined | -1.48 M undefined |
| 2014 | 0 undefined | -1.15 M undefined | -1.2 M undefined |
| 2013 | 0 undefined | -3.27 M undefined | -2.84 M undefined |
| 2012 | 0 undefined | -2.51 M undefined | -1.86 M undefined |
| 2011 | 0 undefined | -350,000 undefined | -1.4 M undefined |
| 2010 | 0 undefined | -10,000 undefined | -20,000 undefined |
| 2009 | 0 undefined | -20,000 undefined | 0 undefined |
| 2008 | 0 undefined | -20,000 undefined | -30,000 undefined |
| 2007 | 0 undefined | -10,000 undefined | -20,000 undefined |
| 2006 | 0 undefined | 10,000 undefined | 10,000 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2006 | 0 USD | 10,000 USD | 10,000 USD |
| 2007 | 0 USD | -10,000 USD | -20,000 USD |
| 2008 | 0 USD | -20,000 USD | -30,000 USD |
| 2009 | 0 USD | -20,000 USD | 0 USD |
| 2010 | 0 USD | -10,000 USD | -20,000 USD |
| 2011 | 0 USD | -350,000 USD | -1.4 M USD |
| 2012 | 0 USD | -2.51 M USD | -1.86 M USD |
| 2013 | 0 USD | -3.27 M USD | -2.84 M USD |
| 2014 | 0 USD | -1.15 M USD | -1.2 M USD |
| 2015 | 0 USD | -1.39 M USD | -1.48 M USD |
| 2016 | 0 USD | -631,000 USD | -916,000 USD |
| 2017 | 0 USD | -1.48 M USD | -2.97 M USD |
| 2018 | 0 USD | -3.63 M USD | -3.28 M USD |
| 2019 | 0 USD | -3.17 M USD | -3.45 M USD |
| 2020 | 0 USD | -2.44 M USD | -4.93 M USD |
| 2021e | 0 USD | 0 USD | 0 USD |
| 2022e | 0 USD | 0 USD | 0 USD |
| 2023e | -9,179.24 TT USD | 0 USD | -486.32 M USD |
| 2024e | -9,236.1 TT USD | 0 USD | -486.32 M USD |
Wize Pharma stock margins US97751M2070 ·
The Wize Pharma margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Wize Pharma. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Wize Pharma.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Wize Pharma's sales revenue. A higher gross margin percentage indicates that the Wize Pharma retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Wize Pharma's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Wize Pharma's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Wize Pharma's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Wize Pharma. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Wize Pharma's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Wize Pharma Margin History
| Wize Pharma Gross margin | Wize Pharma Profit margin | Wize Pharma EBIT margin | Wize Pharma Profit margin |
|---|---|---|---|
| 2024e | 0 % | 0 % | 0 % |
| 2023e | 0 % | 0 % | 0 % |
| 2022e | 0 % | 0 % | 0 % |
| 2021e | 0 % | 0 % | 0 % |
| 2020 | 0 % | 0 % | 0 % |
| 2019 | 0 % | 0 % | 0 % |
| 2018 | 0 % | 0 % | 0 % |
| 2017 | 0 % | 0 % | 0 % |
| 2016 | 0 % | 0 % | 0 % |
| 2015 | 0 % | 0 % | 0 % |
| 2014 | 0 % | 0 % | 0 % |
| 2013 | 0 % | 0 % | 0 % |
| 2012 | 0 % | 0 % | 0 % |
| 2011 | 0 % | 0 % | 0 % |
| 2010 | 0 % | 0 % | 0 % |
| 2009 | 0 % | 0 % | 0 % |
| 2008 | 0 % | 0 % | 0 % |
| 2007 | 0 % | 0 % | 0 % |
| 2006 | 0 % | 0 % | 0 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2006 | 0 % | 0 % | 0 % |
| 2007 | 0 % | 0 % | 0 % |
| 2008 | 0 % | 0 % | 0 % |
| 2009 | 0 % | 0 % | 0 % |
| 2010 | 0 % | 0 % | 0 % |
| 2011 | 0 % | 0 % | 0 % |
| 2012 | 0 % | 0 % | 0 % |
| 2013 | 0 % | 0 % | 0 % |
| 2014 | 0 % | 0 % | 0 % |
| 2015 | 0 % | 0 % | 0 % |
| 2016 | 0 % | 0 % | 0 % |
| 2017 | 0 % | 0 % | 0 % |
| 2018 | 0 % | 0 % | 0 % |
| 2019 | 0 % | 0 % | 0 % |
| 2020 | 0 % | 0 % | 0 % |
| 2021e | 0 % | 0 % | 0 % |
| 2022e | 0 % | 0 % | 0 % |
| 2023e | 0 % | 0 % | 0 % |
| 2024e | 0 % | 0 % | 0 % |
Wize Pharma Aktienanalyse
What does Wize Pharma do?
Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Wize Pharma's Profit Margins
The profit margins of Wize Pharma represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Wize Pharma's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Wize Pharma's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Wize Pharma's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Wize Pharma’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Wize Pharma stock
How has the profit developed compared to last year?
The profit has increased by 0% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Wize Pharma publish its earnings?
Wize Pharma publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Wize Pharma?
The profits of Wize Pharma are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Wize Pharma?
You can learn more about the earnings of Wize Pharma by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Wize Pharma pay?
Over the past 12 months, Wize Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Wize Pharma is expected to pay a dividend of 0 USD.
What is the dividend yield of Wize Pharma?
The current dividend yield of Wize Pharma is .
When does Wize Pharma pay dividends?
Wize Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Wize Pharma?
Wize Pharma paid dividends every year for the past 0 years.
What is the dividend of Wize Pharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Wize Pharma located?
Wize Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von Wize Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Wize Pharma from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.
When did Wize Pharma pay the last dividend?
The last dividend was paid out on 10/1/2024.
What was the dividend of Wize Pharma in the year 2023?
In the year 2023, Wize Pharma distributed 0 USD as dividends.
In which currency does Wize Pharma pay out the dividend?
The dividends of Wize Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Wize Pharma
Our stock analysis for Wize Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Wize Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
